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ABSTRACT 25 
Background: Our previous work has shown that oral supplementation with inulin propionate 26 
ester (IPE) reduces intra-abdominal fat and prevents weight gain and that oral propionate 27 
intake enhances resting fat oxidation. The effects of IPE combined with exercise training on 28 
energy substrate utilisation are unknown. The aim of this study was to investigate the impact 29 
of 4-weeks IPE supplementation, in combination with a moderate intensity exercise training 30 
programme, on whole body fat oxidation and on plasma GLP-1 and PYY.  31 
Methods: Twenty overweight healthy women participated in randomised parallel study and 32 
underwent 4 weeks of supervised exercise training either with IPE (EX/IPE group) or Placebo 33 
(EX/Placebo group) supplementation. Before and after the intervention participants conducted 34 
an experimental trial, which involved collection of expired gas and blood samples in the fasted 35 
state and during 7 hours of the postprandial state.  36 
Results:  Within groups, the EX/IPE group significantly enhanced the amount of fat (Pre, 24.1 37 
± 1.2 g; Post, 35.9 ± 4.0 g, P< 0.05) oxidised and reduced CHO (Pre,77.8  ± 6.0  g; Post, 57.8 38 
± 7.7 g,  P< 0.05) oxidised,  reduced body weight (Pre, 77.3 ± 4.2 kg; Post, 76.6 ± 4.1 kg, P< 39 
0.05) and body fat mass (Pre, 37.7 ± 1.9 %; Post, 36.9 ± 1.9 %, P< 0.05). In EX/Placebo group,  40 
changes in amount of fat (Pre, 36.8 ± 3.9 g; Post, 37.0 ± 4.0 g) and CHO  (Pre, 62.7 ± 6.5g; 41 
Post, 61.5 ±7.4 g) oxidized, body weight (Pre, 84.2 ± 4.3 kg; Post, 83.6 ± 4.3 kg) and body fat 42 
mass (Pre, 40.1 ± 1.9 %; Post, 38.7 ± 1.5 %) were not significant. Comparing between groups, 43 
change in the amount of fat oxidised was significantly (P<0.05) higher for EX/IPE compared 44 
with EX/Placebo and there was a trend for difference for amount of CHO oxidised (P=0.06) 45 
and RER (P=0.06). Energy expended was not significantly different (P>0.05). The 46 
interventions had no impact on fasting or postprandial plasma concentrations of GLP-1 and 47 
PYY.  48 
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Conclusion: Moderate intensity exercise training programmes when combined with daily oral 49 
IPE supplementation may help overweight women to achieve increase in fat oxidation. 50 
 51 
The study was registered at clinicaltrials.gov as NCT04016350. 52 
 53 
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1. Introduction 74 
Increasing exercise is important in obesity reduction strategies, inducing negative energy 75 
balance driven by increasing energy expenditure [1]. However, the effectiveness of exercise 76 
induced weight loss in the absence of caloric restriction remains controversial and is highly 77 
individual [2-5]. In healthy overweight women, who participated in 7 week-endurance-type 78 
exercise programme and achieved variable changes in fat mass and fat oxidation, energy 79 
expenditure and the change in resting fat oxidation were the only statistically significant 80 
independent predictors of change in fat mass [6]. This suggests that strategies maximizing 81 
resting fat oxidation may enhance body fat mass loss alongside exercise in overweight and 82 
obese individuals.   83 
The short chain fatty acid (SCFA) propionate, produced through fermentation of dietary 84 
fibre by the gut microbiota, has a range of metabolic benefits [7]. Previous work has reported 85 
that that a single dose of oral sodium propionate increased both resting energy expenditure and 86 
resting fat oxidation in humans [8]. These findings are in line with a recent report that rectal 87 
SCFA infusion, high in propionate, increases resting energy expenditure and fat oxidation in 88 
overweight men [9]. Together, these data suggest that increasing propionate production in the 89 
gut may be useful in an overall weight management strategy. We developed inulin propionate 90 
ester (IPE) to target delivery of propionate to the colon, mimicking high-fibre dietary intake 91 
using a modest supplement dose [10].  92 
Thus, the main aim of this study was to investigate the impact of daily IPE supplementation 93 
combined with 4-week exercise training programme on whole-body fat oxidation and body fat 94 
change in overweight women.  Since our previous study [10] reported that acute ingestion of 95 
10 g IPE significantly increased postprandial plasma PYY and GLP-1, and that this effect on 96 
the incretin response was lost following long-term (24-week) supplementation, this study also 97 
investigated the postprandial anorexigenic gut hormones response. 98 
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2. Participants and Methods 99 
This single blinded randomised parallel study was conducted on healthy overweight females 100 
with BMI >25 kg/m2 and 25-45 years of age. Study participants underwent 4 week supervised 101 
moderate intensity exercise training combined either with IPE (EX/IPE) or cellulose as placebo 102 
(EX/Placebo) supplementation. Before and at the end of the 4-week intervention, participants 103 
underwent body weight and body composition measurements, conducted a submaximal 104 
exercise test and a 7-hour experimental trial, which involved collection of expired air and blood 105 
samples in fasted and postprandial states. Detailed description of the participants, study design 106 
and methods are available in the online-only Supplementary Material.  107 
 108 
3. Results 109 
3.1. Changes in body weight and body fatness  110 
Physical characteristics of the participants measured before and after 4-week interventions are 111 
presented in Supplementary Table 1. Participants of the EX/Placebo group (n=11) exercised 112 
at a HR of 146 ± 4 beat·min-1, which corresponded to 61 ± 1 % of the predicted maximal 113 
oxygen consumption and the participants of the EX/IPE (n=9) group exercised at a HR of 142 114 
± 5 beat·min-1, which corresponded to 60 ± 2% of the predicted maximal oxygen consumption. 115 
The total energy expenditure of the exercise programmes was not significantly different 116 
between groups (EX/Placebo, 5768 ± 412; EX/IPE, 5469 ± 390 kcal) and body weight loss of 117 
0.77 ± 0.16 kg and 0.74 ± 0.17 kg was expected in EX/Placebo and EX/IPE groups, 118 
respectively. In the EX/Placebo group, the 4-week exercise programme had no effect (P>0.05) 119 
on mean body weight, BMI, body fat mass and body fat percentage whereas in the EX/IPE 120 
group post-intervention body weight, BMI, body fat mass and body fat percentage were 121 
significantly (P<0.05) lower in comparison to the pre-intervention values The differences 122 
6 
 
between body weight and body fat changes in EX/Placebo and EX/IPE groups were not 123 
significant but in the EX/IPE group responses were less variable. 124 
3.2. Fat and CHO oxidation during 7-hour trials 125 
In EX/Placebo group, four weeks of intervention had no significant impact on fat and CHO 126 
oxidation rates while in the EX/IPE group difference in pre- and post-intervention rate of fat 127 
oxidation was significant (P<0.05, two-way ANOVA, trial effect) (Figure 1). In the 128 
EX/Placebo group, the intervention had no impact on total amount of fat and CHO oxidised 129 
while in the EX/IPE group intervention increased the amount of fat (P<0.05) and reduced the 130 
amount of CHO (P<0.05) oxidized (Table 1). Comparing between groups, changes in the 131 
amount of fat oxidised were significantly (P<0.05) different and a trend for difference was 132 
observed for amount of CHO oxidised (P=0.06) and RER (P=0.06). Energy expended was not 133 
significantly different (P>0.05) (Table 1).  134 
3.3 Appetite-related gut hormones  135 
In both, the EX/Placebo and EX/IPE groups, four weeks of intervention had no significant 136 
effect on plasma concentrations of plasma GLP-1 and PYY (P>0.05, two-way ANOVA, trial 137 
effects). Comparing between groups, changes in time-averaged areas under the responses of 138 
PYY or GLP-1 versus time curves were not statistically different (Supplementary Table 2). In 139 
EX/IPE group, time averaged areas under the curve of GLP-1 measured during both, pre-140 
intervention and post-intervention trials, were significantly (P<0.05, unpaired t-test) higher 141 
than in EX/Placebo group while pre-intervention and post-intervention concentrations of PYY 142 
were not different between EX/IPE and Ex/Placebo groups (Supplementary Table 2).  143 
4. Discussion 144 
This first-in-human study demonstrates that IPE supplementation leads to increased resting 145 
whole-body fat oxidation in the postprandial state when combined with moderate intensity 4-146 
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week exercise programme in overweight women. We found that the change in the amount of 147 
fat oxidised during seven hours of the experimental trial was significantly higher in the IPE 148 
than Placebo group and the difference in the change in fat oxidations between groups 149 
consisted of approximately 10 grams. Thus, the beneficial effects observed on fat oxidation 150 
with single dose propionate oral consumption [8] translate into other physiological states, 151 
including during exercise training. As in some other studies [11,12] resting fat oxidation was 152 
not affected by four weeks exercise training combined with placebo. Thus, enhanced fat 153 
oxidation seen in IPE group most likely relates to daily intake of IPE rather than to 154 
participation in the exercise programme. We note that fat oxidation measurements were 155 
conducted at least 18 hours after intake of the last IPE dose. Thus, supplementation with IPE 156 
had a long-term rather than acute effect on resting fat oxidation.  157 
As in majority of exercise training studies without dietary restriction [13], predicted 158 
body weight loss was modest and not clinically significant (≤5% weight loss). In the control 159 
group intervention had no significant effect on mean body weight and body fatness and as in 160 
other studies [4-6, 14] the responsiveness to exercise training was also variable. The IPE 161 
group achieved a significant reduction in body weight and body fatness and changes were 162 
less variable than in the control group. Taking into consideration that in the control group, 163 
changes in fat oxidation were found only in some participants and that in IPE group fat 164 
oxidation was enhanced in all participants, our data support the hypothesis that increase in fat 165 
oxidation during exercise programmes is important for achieving improvements in body 166 
weight and body fat. Further work is required to assess if the effects on body mass and 167 
composition over longer duration persist with IPE in well-designed randomised controlled 168 
trials. 169 
We also found that IPE supplementation during exercise programme  had no impact on plasma 170 
concentrations of GLP-1 and PYY. This observation is novel and important and suggests that 171 
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GLP-1 and PYY response to IPE is attenuated within 4 weeks and thus persists much shorter 172 
than we previously reported in a 24-week intervention study [10]. However, as with fat 173 
oxidation measurements, collection of blood for hormone measurements occurred 18-24 hours 174 
after intake of the last IPE dose and thus acute elevation GLP-1 and PYY after IPE cannot be 175 
ruled out. The finding that concentrations of GLP-1 and PYY were not modified by exercise 176 
intervention alone is consistent with findings from other similar studies [5,15].  177 
This study has limitations. Data obtained in this study do not allow to establish 178 
causality between IPE induced change in fat oxidation and change in body fatness. This 179 
should be investigated by future studies which include measurements of behavioural 180 
compensatory variables such as changes in energy intake and energy expenditure of physical 181 
activity outside exercise sessions, known to contribute to the responsiveness to exercise 182 
training programmes [16-18]. It is possible that increasing the number of participants could 183 
lead to significant changes in GLP-1 and PYY concentrations in IPE group and differences 184 
between post- and pre-intervention CHO oxidation were seen at additional time points. We 185 
note that this was a preliminary study and we had no way to formally calculate a sample size 186 
for study outcomes. Thus, with the data from the present study, further appropriately 187 
powered, randomised controlled trials to investigate the longer-term effects of IPE on body 188 
weight in both men and women alongside prescribed exercise interventions are warranted. 189 
Considering appetite regulating hormones beyond GLP-1 and PYY [19] will also be 190 
important in future studies.  191 
In conclusion, this study demonstrates that adding IPE to moderate intensity exercise 192 
programmes, applied to overweight women, achieves an increase in whole-body resting fat 193 
oxidation.  194 
 195 
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Figure Legends 280 
 281 
Figure 1. Rate of fat and carbohydrate (CHO) oxidation, and energy expenditure (EE) 282 
in the fasted state (0h) and during post-breakfast (0-180min) and post-lunch (180-420 283 
min), measured   before (Week 0) and after 4-week exercise intervention (Week 4) 284 
combined with Placebo (Ex/Placebo group, n=11) and Inulin Propionate Ester 285 
(Ex/IPE group, n = 9) supplementation. Values are means ± SEs.*Significant 286 
(P<0.05) difference at corresponding time points. 287 
  288 
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Table 1. Total amount of fat and carbohydrate (CHO) oxidised, time averaged respiratory 289 
exchange ratio (RER) and energy expended (EE) during 7 hours of the experimental trial 290 
conducted before (Week 0) and after (Week 4) the exercise programme conducted with placebo 291 
(EX/Placebo) and inulin propionate ester (EX/IPE). All values are mean ± SEM. 292 
 EX/Placebo (n=11) EX/IPE (n=9) P value 
 Week 0 Week 4 Week 0 Week 4  
Fat (g) 31.3 ± 2.4 33.0 ± 2.3 24.1 ± 1.2 35.9 ± 4.0a 0.02 
CHO (g) 69.3 ± 6.0 64.6 ± 6.9 77.8 ± 5.9 57.8 ± 7.7a 0.06 
RER 0.85 ± 0.01 0.84 ± 0.01 0.87 ± 0.01 0.84 ± 0.02 0.06 
EE (kcal) 551 ± 13 549 ± 14 540 ± 14 531 ± 25 0.64 
P value are for difference between change in Ex/Placebo and EX/IPE groups. a Significant 293 
(P<0.05) difference between Week 4 and Week 0 in corresponding group. 294 
  295 
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SUPPLEMENTARY MATERIAL 312 
Participants  313 
Healthy overweight females with BMI >25 kg/m2 and 25-45 years of age were recruited 314 
through advertisements and word of mouth on the campus of the University of Glasgow or 315 
from other public places. Participants were required to be sedentary, non-smokers, with stable 316 
body weight for two months prior to the study enrolment, not pregnant, free of medication, 317 
nutritional supplementation or following any specific diet and with no antibiotic use for the 318 
past three months. Participants with chronic illness, eating disorders and history of 319 
gastrointestinal operations were excluded. All participants gave written informed consent. 320 
The Ethics Committee of the College of Medical, Veterinary and Life Sciences of the 321 
University of Glasgow approved the study (Project Number: 200140132). Study started in 322 
February 2015 and was completed in June 2017.  323 
Study design overview 324 
This was a single blinded randomised parallel study. Study participants underwent 4 week 325 
supervised moderate intensity exercise training combined either with IPE (EX/IPE) or cellulose 326 
as placebo (EX/Placebo) supplementation at doses of 10g/day. Random allocation of the 327 
participants was achieved by chance procedure and conducted by one of the researchers.  After 328 
the assignment to the intervention the participants were blinded in relation to the supplement.  329 
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Cellulose and IPE were provided as sachets containing 10g of white powder and participants 330 
were asked to consume one sachet per day with breakfast. Participants were advised to take 331 
supplements with water or any juice which they include habitually in their breakfast. Empty 332 
sachets were returned and counted as a measure of compliance. Before the start of the study 333 
and at the end of the 4-week intervention, participants were asked to conduct a submaximal 334 
exercise test. Prior to the first and after the second submaximal exercise test, participants of 335 
both groups conducted a 7-hour experimental trial which involved collection of expired air and 336 
blood samples in fasted and postprandial states. Body weight and body composition were 337 
measured in the fasted state. Prior to the first 7-hour experimental trial, participants were asked 338 
to record their diet for 3 days and replicate this intake prior to the second 7-hour experimental 339 
trial.  For training sessions all participants were given free access to the University of Glasgow 340 
Sports Centre. 7-hour experimental trials and submaximal tests were conducted at the 341 
metabolic investigation laboratories of Glasgow University (West Medical and New Lister 342 
Buildings)   343 
7-hour experimental trials 344 
On the morning of each experimental trial, participants reported to the metabolic research unit 345 
between 8:00 and 9:00 a.m. after an overnight fast. After anthropometric and body composition 346 
measurements participants laid supine on the bed with their head resting on pillow and expired 347 
gas was collected. Following this, a venous cannula was inserted into an antecubital vein and 348 
after 10 minutes a baseline blood sample was collected. Participants were then asked to 349 
consume a standardised breakfast and after four hours a standardised lunch. Further expired air 350 
samples and blood samples were collected at 1-hour intervals. The test breakfast consisted of 351 
butter croissant, chocolate spread, whole milk, double cream, milkshake powder and sugar 352 
providing 1 g fat, 1.2 g carbohydrate, 0.25 g protein and 15 kcal energy per kg body mass. The 353 
test lunch consisted of white bread, mild cheddar cheese, butter, potato crisps, whole milk, 354 
double cream, milkshake powder and sugar providing 0.8 g fat, 1.1 g carbohydrate, 0.35 g 355 
protein, 13 kcal energy per kg of body mass. Breakfast and lunch were identical in both 356 
experimental trials and were served in a standardized way. 357 
Submaximal exercise test  358 
The test was conducted on a treadmill (Trackmaster Treadmills, Full Vision, Inc., Kansas, 359 
USA). After a 4-minute warm-up (walking on treadmill at 3.5 km/h), participants walked on 360 
the treadmill at a constant speed of 5 or 5.5 km/hour with the incline being increased by 2% 361 
every 4 minutes. The whole test consisted of 4 to 6 stages and therefore lasted from 16 to 24 362 
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minutes. The test was terminated once the participant reached 85% of their aged-predicted 363 
maximal heart rate (HRmax = 220 – age). During the last minute of each 4-minute stage, HR 364 
was recorded via a heart rate monitor (Polar Sports Tester, Polar Electro Oy, Kempele, 365 
Finland), rate of perceived exertion (RPE) was indicated by the participant on the Borg scale 366 
(Borg et al., 2010) and an expired air sample was collected by Douglas bag method.  Expired 367 
air samples were analysed through a gas analyser (1440 Gas Analyser, Servomex, UK) and 368 
maximal oxygen consumption (V̇O2 max) was predicted by extrapolation of the HR against 369 
V̇O2 plot to age-predicted maximum HR. Data obtained during submaximal tests were used to 370 
predict the intensity at which each participant exercised and the energy expenditure of the  371 
Exercise training sessions 372 
Exercise training consisted of four weekly sessions of endurance type exercise (treadmill, cycle 373 
ergometer or cross-trainer). Timing of the training sessions was agreed between investigator 374 
and the participant and was based on the participant’s availability. The duration of the exercise 375 
sessions was 30, 40, 50 and 60 minutes for weeks 1, 2, 3 and 4, respectively. Participants were 376 
asked to exercise at an individual pre-determined work rate and achieve 60-65 % of their 377 
predicted V̇O2 max with HR being recorded every 5 minutes using heart rate monitors (Polar 378 
Sports Tester, Polar Electro Oy, Kempele, Finland). All exercise sessions were supervised by 379 
a researcher. Total net energy expenditure of the exercise intervention was determined from 380 
heart rate obtained in the exercise sessions and individual relationships of the heart rate versus 381 
oxygen uptake obtained during submaximal tests.  382 
Expired gas collection and analyses during 7-hour trials 383 
Expired gas was collected and analysed by computerised open-circuit ventilated hood system 384 
(Oxycon Pro, Germany). After volume and gas calibrations of the apparatus, participants were 385 
instructed to lay supine and be still and awake during the measurement. Once comfortable, a 386 
clear plastic canopy (weight, 550 g; dimensions, 19.6 x 12.99 x 9.44 inc) was placed on the 387 
participant’s head and expired gas was collected after each blood sample collection for the 388 
duration of 20 minutes. Values of oxygen consumption (V̇O2) and carbon dioxide production 389 
(V̇CO2) rates were recorded every 30 seconds and averaged prior to calculations of the 390 
respiratory exchange ratio  (RER) and fat and CHO oxidation, and rate of energy expenditure 391 
[1]:   392 
Fat Oxidation (g/min) = (V̇O2 - V̇CO2) / 0.57 393 
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CHO Oxidation (g/min) = (1.40 x V̇CO2 - V̇O2) / 0.57 394 
Energy Expenditure (kJ/min) = (CHO oxidation x 15.6) + (fat oxidation x 39) 395 
RER= V̇CO2/ V̇O2 396 
Anthropometric and body composition measurements 397 
Height was measured to the nearest 0.5 cm using a stadiometer (Seca, Leicester, UK). Body 398 
mass and body fatness were measured by leg-to-leg bioelectrical impedance scales (TBF-300, 399 
TANITA, Cranela, UK). Height was determined using standard protocol.  400 
 Blood sample analysis 401 
Venous blood samples were collected in ethylenediamine tetra-acetic acid (EDTA) coated 402 
evacuated tubes (Greiner Bio-One, Kremsmünster, Austria). Tubes containing blood samples 403 
were immediately placed on ice and then centrifuged at 4°C, 3000 rpm for 15 minutes (Hettich 404 
D-78532 Universal 320 R Centrifuge, Tuttiligen, Germany). Plasma was dispensed in 0.5 mL 405 
aliquots into labeled sterilized micro-centrifuge cap tubes and kept at –80°C until analysis. For 406 
analysis, plasma samples were allowed to thaw and then were centrifuged for a few seconds to 407 
ensure plasma is mixed and there is no sediment. Commercial ELISA kits were used to measure 408 
concentration of plasma GLP-1 (Merck, Millipore, Bioscience Division, UK) and PYY 409 
(Merck, Millipore, Bioscience Division, UK). Coefficients of variation (CVs) were <8% for 410 
both, GLP-1 and PYY assays.   411 
Statistical analysis 412 
For non-normally distributed data, statistical analysis was performed following log10 413 
transformation. Data on fat and CHO oxidation, energy expenditure and appetite hormones 414 
were analysed by two-way (time and trial effects) repeated measures ANOVA, followed by 415 
post hoc Tukey test.  Amount of total fat and CHO oxidised and energy expended during seven 416 
hours of the trial within group were compared by paired t-test while changes in these measures 417 
between groups were compared by independent t-test. For all tests, the significance level was 418 
accepted at P<0.05. Statistical analysis was performed using Minitab (version 17.3.1; Minitab, 419 
Inc. State College, PA) and Statistica (version 10.0; StatSoft, Inc. Tulsa, OK). 420 
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Supplementary Table 1. Physical characteristics of the participants before (Week 0) and after 448 
(Week 4) the exercise intervention conducted with placebo (EX/Placebo) and inulin propionate 449 
ester (EX/IPE). Values are mean ± SEM. 450 
 EX/Placebo  EX/IPE   
 Week 0 Week 4 Week 0 Week 4 P value 
Age (y) 26.8 ± 0.94 - 29.3 ± 1.54 -  
Weight (kg) 79.4 ± 3.3 79.1 ± 3.4 77.3 ± 4.2 76.6 ± 4.1a 0.47 
BMI (kg/m2) 29.0 ± 1.1 28.9 ± 1.2 29.4 ± 2.2 29.0 ± 1.9a 0.36 
Fat mass (kg) 30.9 ± 2.6 30.7 ± 2.7 29.8 ± 3.2 28.8 ± 3.2a 0.45 
Body Fat (%) 38.3 ± 1.6 37.2 ± 1.1 37.7 ± 1.9 36.9 ± 1.9a 
0.51 
V̇O2max (ml/kg/min) 32.4 ± 1.2             34.2 ± 1.2
a  30.0 ± 1.0 33.0 ± 1.9a 0.82 
BMI, Body Mass Index; V̇O2max, maximal oxygen consumption.  451 
P values are for difference between change in Ex/Placebo and EX/IPE groups.  452 
a Significant (P<0.05) difference between Week 4 and Week 0 in corresponding group. 453 
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Supplementary Table 2. Time-averaged areas under plasma concentrations of YY (PYY) and 
GLP-1 versus time curves during post-breakfast (0-3 hours), post-lunch (3-7hours) period and 
the entire period (0-7 hours) of the experimental trial conducted before (Week 0) and after 
(Week 4) the exercise intervention with placebo (EX/Placebo) and inulin propionate ester 
(Ex/IPE) and change (∆)  in time averaged area under the curve between week 4 and week 0 in 
corresponding group. Values are presented as Mean ± SE.  
 Week 0 Week 4 ∆ Week 0 Week 4 ∆ P  
PYY         
  0-3 h 101.3 ± 11.9 95.6 ± 9.8 -5.7 ± 7.9 89.8 ± 10.0  102.2 ± 8.6 12.4 ± 8.0 0.7 
  3-7 h 124.4 ± 12.4 119.3 ± 11.9 -5.1 ± 8.1 110.0 ± 11.0 114.9 ± 12.8 4.9 ± 5.9 0.3 
  0-7 h 113.8 ± 11.5 109.7 ± 10.8 -4.1 ± 6.6 98.1 ± 10.9 108.4 ± 9.8 10.4 ± 6.9 0.2 
GLP-1         
  0-3 h 29.4 ± 3.6 28.2 ± 4.3 -1.2 ± 2.1 39.5 ± 6.7a 40.3 ± 5.4b 0.8 ± 2.8 0.6 
  3-7 h 27.8 ± 3.5 26.6 ± 4.0 -1.2 ± 1.8 41.0 ± 6.1a 45.0 ± 5.0b 4.0 ± 3.4 0.4 
  0-7 h 28.5 ± 3.5 27.2 ± 4.1 -1.3 ± 1.8 40.0 ± 6.3a 43.6 ± 5.4b 3.5 ± 2.5 0.3 
P for difference between change in EX/Placebo and EX/IPE groups. a Significantly different 454 
(P<0.05) from Week 0 values in EX/Placebo group; b Significantly different (P<0.05) from 455 
Week 4 values in EX/Placebo group. 456 
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